Overall, current evidence suggests that AM has preliminary renoprotective potential in experimental AKI models, however, the limited number of available studies, predominance of cisplatin-induced nephrotoxicity models, insufficient pharmacokinetic and safety data, and absence of human clinical studies preclude conclusi...
Atthaphong Phongphithakchai, Nawanwat C. Pattaranggoon, Kraiyasak Wongna et al.· Antioxidants· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.